News > Methotrexate Shortage Has Many Concerned - Arthritis Today

News > Methotrexate Shortage Has Many Concerned Arthritis Today That's because the majority of arthritis patients who take methotrexate – which is used in the treatment of rheumatoid arthritis, psoriatic arthritis, lupus and certain types of juvenile arthritis – use the pill form, There is no shortage of that right ...

UCB's Future Plans for Cimzia - Zacks.com

UCB's Future Plans for Cimzia Zacks.com UCB (UCBJF) recently reported positive data from a late-stage trial (RAPID-PsA) on Cimzia (certolizumab pegol), which is being studied in patients suffering from psoriatic arthritis. The 48-week study demonstrated that after 12 weeks of treatment with ... and more »

Positive data for Cimzia sets up filing in psoriatic arthritis - PMLiVE

Positive data for Cimzia sets up filing in psoriatic arthritis PMLiVE Belgian pharma company UCB says it is planning to file for approval of its Cimzia product in psoriatic arthritis later this year after a phase III trial backed its efficacy and safety in this setting. In Europe, Cimzia (certolizumab pegol) is already ... and more »

UCB's Cimzia effective for psoriatic arthritis - Pharma Times

UCB's Cimzia effective for psoriatic arthritis Pharma Times UCB is looking to expand the label on Cimzia on the back of impressive late-stage data for the monoclonal antibody in psoriatic arthritis. The Belgian drugmaker has published top-line results from a Phase III study evaluating Cimzia (certolizumab ... Positive top-line result for UCB's Cimzia in psoriatic arthritisPharmaLive.com (press release) all 6 news articles »